{"name":"CalciMedica, Inc.","slug":"calcimedica-inc","ticker":"","exchange":"","domain":"calcimedica.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"CM4620-IE","genericName":"CM4620-IE","slug":"cm4620-ie","indication":"Atrial fibrillation for stroke prevention","status":"phase_2"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Standard of Care (Part 1)","genericName":"Standard of Care (Part 1)","slug":"standard-of-care-part-1","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"CM4620-IE","genericName":"CM4620-IE","slug":"cm4620-ie","phase":"phase_2","mechanism":"CM4620-IE is a small molecule that targets the calcium channel.","indications":["Atrial fibrillation for stroke prevention"],"catalyst":""},{"name":"Standard of Care (Part 1)","genericName":"Standard of Care (Part 1)","slug":"standard-of-care-part-1","phase":"marketed","mechanism":"Standard of Care (Part 1) refers to the established first-line treatment protocol for a given condition, which varies by indication and is not a specific drug entity.","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFAwQXJXRkgyMjNEUU82UUl6TFFaUGJKbDN0US1uXzVnN1NFMW9PNlB2NE8zM2Zza3BtNGZVNzVocGdxT294VUhMRVZacUVQSEV3TU9SaEhpWnREd2wxTXhVanNGNzBtSk5uNHgtbHdR?oc=5","date":"2026-03-22","type":"pipeline","source":"Stock Titan","summary":"If You Invested $1,000 in CALCIMEDICA INC (CALC) - Stock Titan","headline":"If You Invested $1,000 in CALCIMEDICA INC (CALC)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxQVTJ5R1F6RDJDeU9acHBhWmdyMEpDLVJ0cl9pNldZd2hyX3liZU9JNjYwU1JkTVBXWnE3WVM0SS1hUGg2SnhIck1tRkpuRVNTYVZtMDYyckRIdHB6MnRaekpTUjBWYl95Ny1SYVdkc0tnN081NVNwWHRORHpkaDM3amxVYzBfY05EQWk2U2YzUUMyVmx2dUVGMEl1WkI?oc=5","date":"2026-03-12","type":"pipeline","source":"Stock Titan","summary":"[EFFECT] CalciMedica, Inc. SEC Filing - Stock Titan","headline":"[EFFECT] CalciMedica, Inc. SEC Filing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwJBVV95cUxNMkk1bFlVZjdlakhxcUtaUEZxcV9ucTNYejRpTTRhTjF0YzR4d0hNaDNOeE05QkozM2FZX0E0a3Y0ZmlnYWxuLTlBeDg4dW1iTkx4QldMWnBDNHdsRlhBN28xcjNnTzJrSWM0WXROTkh6SjNnbHBwbXNkcDVJdXBfc1VkaTltMWdTdW9Oa0E4SHh2NnFZYnVKUTlXMWYzNEJrNDljdlFUTnhPenZTVTlJUXl1ZGp6T3BsSU03cVpiNU5hdUpJLWlrbjhlelNaQWJ6NEVfZG12NW4tTEtRVlAtS2F0TjEtb0ptaFRaUFY1ZXpxQWg3bG0tNzdQS2d5UEF3OWJj?oc=5","date":"2026-03-04","type":"pipeline","source":"The Globe and Mail","summary":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: CalciMedica (CALC) and Talphera (TLPH) - The Globe and Mail","headline":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: CalciMedica (CALC) and Talphera (TLPH)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxOZDJVdjJuNWo4SkZaTl8tS0pmTXE3bEl1RDVOTzdHS3E5TXo3M2swaWxTUEt3U2Y2c044N09SYVhvYU9oX3hJZ3N5LS00QTBLYTVoU1RPaFlFN3lmY1lxeDZZb1lmUkJ3ZDdYelBxaFdMRGVqM0VEMEthalE3cENmS0ZUMTJSeUsxbHpPQUtqanFjWkc1bDZOU0t5RjlTRF9HYzA4V1FPUWI?oc=5","date":"2026-03-03","type":"pipeline","source":"Stock Titan","summary":"CalciMedica (Nasdaq: CALC) widens 2025 loss while advancing Auxora and PAH candidate - Stock Titan","headline":"CalciMedica (Nasdaq: CALC) widens 2025 loss while advancing Auxora and PAH candidate","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwJBVV95cUxPbjdXRkwzRGxrS1lubUZEYTZJZHNVZnlXbzdKVnNRSzZMbHQybmNJS3M3R2lScWtGR1lzQ1lwT3E0dGZlQmZZb2VVNnYwOWdnYk5qNDhyMnl3OEgwbFpWS2U3Mkl2MnhNVFN4cDhaekxwYkdnSjhxbDA1dGtsa1EwN2QtbEpvQmdONjcxZ1liMFlTd0FTWVBJWDZwWXhTV0doX2lVc3Y3X2xscFZGRW9WdzhvaU5BbVg4NVBlZlEyNHRENG93bU1CZVBGeXhLYVNERGNHaC10MFlzWTV1anFJZ0lzVzN3SDlKcGFJdEhudzFrRHYyOWtkemg1Z0hQNl9tTGdkTFlGNkVuaHNvbHQ4MEpCUExWVzg?oc=5","date":"2026-01-28","type":"trial","source":"PR Newswire","summary":"CalciMedica Announces Discontinuation of Phase 2 KOURAGE Trial in AKI Following Independent Data Monitoring Committee Recommendation - PR Newswire","headline":"CalciMedica Announces Discontinuation of Phase 2 KOURAGE Trial in AKI Following Independent Data Monitoring Committee Re","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxOV3lRV3A2TjNkTTJKdHhTYVljYkswYWdQUy1JUW1XQl9ISTg2LWo2V3piZ0hSazVyNE5YSDVxZVBRalJWbTFwZFpjV0xNTk9vQ3pjVVVYWVJka1V3Z2FVMmdIc0VCeTA5Wnh3dlpFalNWNzd5RjRodEdwLVpoN1N3dlhxdXhrelhaRll3SXp4dFhnRnI5aUc0Z3JjY2hBQ0NXWk9Pd2lOUnY1MG9DcG16MUdpZ1EzeW9ZNnU2Ni00Zzg?oc=5","date":"2026-01-28","type":"trial","source":"Fierce Biotech","summary":"CalciMedica stock craters as calcium channel inhibitor trial stopped over 'safety concern' - Fierce Biotech","headline":"CalciMedica stock craters as calcium channel inhibitor trial stopped over 'safety concern'","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE9QNm93VGhBY2hhbXF1LTBjazZJSTJxOWJuTUo5Q0MyUV9nRHhUa1BnY01iN1JYNzZoRHN5OTVPekZDMnRrMkdsMUphNVZ4SmFYTzFv?oc=5","date":"2025-04-25","type":"pipeline","source":"Stock Titan","summary":"TELO Stock Price, News & Analysis - Stock Titan","headline":"TELO Stock Price, News & Analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxQWkNINWVua09hcFFHT3R0SUN1MUpkZG9KYXdMc2JPOVBORkdqQkdFeW5PYUIzS3NRc29BSC1sOEFSNGhSdkdzTmRReUd1c2Z0UW1BdEoxaWY4M1NXc2FRX0hWMF9oRmpUV29MT0dIeVpPZnFxZ2hpbUpzM0Z0UG5ycUpMZ21rNFRGa1ZWaUxseTVQY3NSRkNWMTI3b3JTRjljamJIQ0pvZWRIOUtndUY4MXhOMko?oc=5","date":"2025-03-05","type":"pipeline","source":"PR Newswire","summary":"CalciMedica Secures Credit Facility for Up to $32.5 Million - PR Newswire","headline":"CalciMedica Secures Credit Facility for Up to $32.5 Million","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxOWk85TkluTUdyVUlOMllNNlJoZ0NxS3J5Rl9QVU5xeFZNelZKNm9LQTRwMmgydHl1aU5UZ2pZSDhtMC0wdjlLa2xqdXFFRXZLdEVNRmxIMzZnbXJaVkhMV0g0M2NGTWphZHZoUzd6NDhhMVM2OENNZVJCdC1jeFNjcUlXV0duR2JFWGU4MlJ0Znh3bXFzMmlXWXh4Nms0NGQxZFc4Vmk4ZFhKVTU1c0JGVDNXdnZKaTNIcEJZaFhwZVhGVjBCSmFKYlQ3OA?oc=5","date":"2024-07-08","type":"pipeline","source":"2 Minute Medicine","summary":"CalciMedica: Auxora Calcium Channel Inhibitor Improves Time to Solids in Patients with Pancreatitis - 2 Minute Medicine","headline":"CalciMedica: Auxora Calcium Channel Inhibitor Improves Time to Solids in Patients with Pancreatitis - 2 Minute Medicine","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxOaWE3UG5JVFRINkRXNVdWMk1nS05feERObWpSMnhSQzV1c3JqQjY1M3ZfdktUNlNUUDUtbnVjWFNnaDQ2N3lwbktLZEpYYVJYMEZVbHNZQnJtTHo0elVoLWpQYVFodUJ4UlBKMm5idUdmdENtdHdQbERueXdzdmlJWTlrZUxCNkxLTUJzRmV6akVDWlU?oc=5","date":"2023-10-30","type":"pipeline","source":"Eyes On Eyecare","summary":"Opthea names new US-based leadership - Eyes On Eyecare","headline":"Opthea names new US-based leadership","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxNV1NOUkg4dlE0ZURyeGVaVHJ2VEhtc3BKMDA2aDcySWh5T2I1dkJrQWpMUDdtblJQZ1ZlSmo1a2c5WXFPVmV6OUpDTW1NSy11R2k1Z241OUVONlhDRzJwOUxEdm15MjJXRlRuN2hqc1pfM2JUVG50Uk5KU0JGY3ZiTW9sT3BwanNJVXVaZVcwSzFWUGlWazVCeVVaaGxBVEphXzMwa2xIYm5ObmtEMlpzaw?oc=5","date":"2023-09-12","type":"pipeline","source":"citybiz","summary":"Mirum Pharmaceuticals Appoints Eric Bjerkholt As Chief Financial Officer - citybiz","headline":"Mirum Pharmaceuticals Appoints Eric Bjerkholt As Chief Financial Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2gFBVV95cUxNdmt3WjZnQmFHV3h0LWdWNG5FV01YOVFaVkREcDJyaGNoM1IycV85Sm1NYXluQ1Vib2p0ZlowY2lDY2E0Z2tHalBYUTh3Wkl5QmZIMFBxdXQyeVRtV2RINFBoSGdIZUd5QnFYUi1jQkN1UTRjZC1STV9GaFlPQnRlN0NkUUlxZ0RtU3dkcXVGcHpyLWRUdUZHOWJzTV9CSTBBMmFsYjdPTjNfQWlWaHR5aVVidTFaWHFpQ3U5MDFQc3IxLWw5STV5N3VGaEJRamljU0huUWRUaW12UQ?oc=5","date":"2020-06-04","type":"pipeline","source":"European Pharmaceutical Review","summary":"Analysis indicates Auxora™ is effective against COVID-19 pneumonia - European Pharmaceutical Review","headline":"Analysis indicates Auxora™ is effective against COVID-19 pneumonia","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_2":1,"marketed":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}